Anna Vlahiotis
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
- Otorhinolaryngology top 2%
Papers in
- Co-authors
- Jay F. PiccirilloEdward L. SpitznagelRamaswamy GovindanNathan PageDaniel MorgenszternWilliam L. ReadRyan M. TierneyKellie L. Flood
- Journals
- Journal of Clinical Oncology (6 papers)Value in Health (4 papers)Journal of Medical Economics (2 papers)JAMA Network Open (1 paper)BMJ Open (1 paper)
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Anna Vlahiotis
33 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 1.4k
- Otorhinolaryngology 160
- Family Practice 55
- Epidemiology 863
- Pulmonary and Respiratory Medicine 811
Countries citing papers authored by Anna Vlahiotis
This map shows the geographic impact of Anna Vlahiotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vlahiotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vlahiotis more than expected).
Fields of papers citing papers by Anna Vlahiotis
This network shows the impact of papers produced by Anna Vlahiotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vlahiotis. The network helps show where Anna Vlahiotis may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Vlahiotis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 10 | |
| 4 | 2020 | 16 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 35 | |
| 7 | Cost sharing and branded antidepressant initiation among patients treated with generics. | 2018 | 4 |
| 8 | 2018 | 53 | |
| 9 | 2018 | 1 | |
| 10 | 2018 | 3 | |
| 11 | 2017 | 21 | |
| 12 | 2015 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2011 | 39 | |
| 15 | 2010 | 19 | |
| 16 | 2010 | 44 | |
| 17 | 2009 | 56 | |
| 18 | 2007 | 51 | |
| 19 | 2007 | 46 | |
| 20 | 2006 | 47 |
About Anna Vlahiotis
Anna Vlahiotis is a scholar working on Family Practice, Otorhinolaryngology, Geriatrics and Gerontology, Immunology and Allergy and Sensory Systems, having authored 36 papers that have together received 2.5k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Bladder and Urothelial Cancer Treatments (5 papers), Renal cell carcinoma treatment (3 papers), Pharmaceutical industry and healthcare (3 papers), Allergic Rhinitis and Sensitization (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Research Studies (3 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Oncology (1.4k citations), Otorhinolaryngology (160 citations), Family Practice (55 citations), Epidemiology (863 citations) and Pulmonary and Respiratory Medicine (811 citations). Anna Vlahiotis has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Jay F. Piccirillo, Edward L. Spitznagel, Ramaswamy Govindan, Nathan Page, Daniel Morgensztern, William L. Read, Ryan M. Tierney, Kellie L. Flood, Ewout W. Steyerberg and Scott Devine. Their work appears in journals such as Journal of Clinical Oncology, Value in Health, Journal of Medical Economics, JAMA Network Open and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.